Abstract
Hypertension has been recognized as a major risk factor for cardiovascular disease. We aimed to analyze the current prevalence, awareness, treatment, and control of hypertension in northeast China. This cross-sectional survey adopted the multistage stratified random cluster sampling method to obtain a representative sample of adults aged 40 years or older in the general population of northeast China. Hypertension was defined as a systolic blood pressure (SBP) ≥ 140 mm Hg, or diastolic blood pressure (DBP) ≥ 90 mm Hg, or self-reported use of antihypertensive medications in the last 2 weeks irrespective of BP. Altogether 4052 participants were included with weighted prevalence of hypertension of 57.3%. Among them, 47.4% were aware of their condition; 78.8% took antihypertensive medication, but only 10.2% had their blood pressure controlled. Individuals who were overweight/obesity, with dyslipidemia, or diabetes were at a higher risk of hypertension; these people also more likely to be aware of their condition. Subjects with a personal history of stroke were more inclined to receive antihypertensive medication, but that did not necessarily translate to well-controlled hypertension. Moreover, dyslipidemia (OR = 0.600; 95% CI: 0.375, 0.960) were associated with poor hypertension control. Subjects using combination of antihypertensive medications (OR = 2.924; 95% CI: 1.606, 5.325) or with a family history of coronary heart disease were more likely to have their blood pressure controlled. Our study identified a high prevalence of hypertension in northeast China. Although awareness and treatment rates improved over the last decade, the control rate remained disproportionately and unacceptably low.
Similar content being viewed by others
Introduction
Hypertension has long been recognized as a worldwide public-health challenge and particularly as a major risk factor for cardiovascular disease and premature death [1, 2]. It was also considered to be the largest contributor to global disability-adjusted life-years in 2015 3]. It is estimated that the proportion of the global adult hypertensive population will increase to 29%, with an estimated 1.56 billion hypertensive individuals in the world by 2025. Most of this increase can be attributed to economically developing regions in the world 4].
With rapid economic development and demographic transitions characterized by striking reductions in fertility and child mortality and increases in life expectancy in the past few decades, the major causes of morbidity and mortality in China have shifted from primarily infectious diseases to chronic, particularly cardiovascular, diseases 5]. As the most important modifiable risk factor for cardiovascular diseases, the age-standardized prevalence of hypertension is declining in higher income countries, whereas low-income and middle-income countries are encountering an increasing burden of hypertension; [2, 6] this is true for China 7].
Although there are several studies on the prevalence of hypertension in northeast China in recent years [8, 9], only limited studies on the influencing factors associated with the awareness, treatment, and control of hypertension have been undertaken. This gap in knowledge is an impediment to develop targeted health policies for the prevention and control of hypertension in this area. The 2015–2016 China National Stroke Screening Survey includes these data and remains the latest cross-sectional survey in northeast China. Using the data from this study, we aimed the following: (1) provide the updated data for the prevalence, awareness, treatment, and control of hypertension in northeast China and (2) investigate the influence factors associated with hypertension among adults aged 40 years and above in this area.
Patients and Methods
Data source and study participants
The China National Stroke Screening Survey was an ongoing stroke surveillance program among residents in China 10]. The details of this study in northeast China and methods have been reported elsewhere 11]. It was conducted from January to March 2016, and supervised by National Center for Stroke Control and Prevention. The most important reason for choosing this period of time was to increase response rate and reduce sample selection bias, in order to make the study sample best representative of the adults aged 40 years or older in this area because many migrant workers living in this area would return home during this period of time for Spring Festival with their families.
This cross-sectional survey adopted the multistage stratified random cluster sampling method to select representative samples. In the first stage, 30 villages and 10 towns were randomly selected from 308 villages (rural) and 14 towns (urban) in Dehui City using probability proportional to size (PPS) sampling. In the second stage, 5 villagers’ groups or communities were sampled from both rural and urban strata using PPS. Finally, 1 adult resident aged 40 years or older was randomly selected from each household of the selected villagers’ groups or communities. Respondents who were unwilling to participate in the survey or judged to very frail were excluded. 4100 permanent residents 40 years and older who had lived in Dehui City of Jilin province for >6 months volunteered to participate in the survey, with an excellent response rate being 92.2%. Ethics approval was obtained from the Human Ethics and Research Ethics committees of the First Hospital of Jilin University, and informed consent was obtained from all participants during recruitment. For the purpose of the present analysis, 48 subjects were excluded due to missing values. Finally, a total of 4052 people were included in the present analysis.
Screening protocol and assessment criteria
All participants were assessed at a central survey site in their area. All adult individuals completed a questionnaire-based interview, physical and clinical examinations.
The questionnaire included information about stroke history, demographic information, and the presence of risk factors. The physical examination involved the measurement of height, weight, neck, waist and hip circumference, and resting blood pressure. Height and weight were measured according to the standardized protocol, with the participants wearing light clothing and without shoes. Blood pressure was measured by trained practitioners using an automatic OMRON sphygmomanometer (OMRON HEM-7200, Kyoto, Japan). Two consecutive measures were taken on the right arm supported at the heart level on seated participants after 20 min of rest, and we took the average of the readings. A blood sample was drawn from the participant’s antecubital vein in the morning after an overnight fast (at least 8 h) for measuring fasting blood glucose (FBG), total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C), and the sample was uniformly measured by Changchun Kingmed Center for Clinical Laboratory Co., Ltd. Supplementary Table S1 presents detailed assessment criteria for other stroke-related factors, including hypertension, diabetes, dyslipidemia, overweight or obesity, physical inactivity, smoking, drinking, etc. referred in this study (Supplementary Table S1).
Diagnostic criteria
Hypertension was defined as an average systolic blood pressure (SBP) of 140 mm Hg or greater, or an average diastolic blood (DBP) of 90 mm Hg or greater, or self-reported diagnosis. Participants who took anti-hypertensive drugs in the last 2 weeks were also considered as having hypertension, regardless of the level of blood pressure measured at the time of the study.
Hypertension awareness was defined as self-reported previous diagnosis before the present survey. Hypertension treatment was defined as the self-reported use of medication for the management of hypertension during the previous 2 weeks. The control rate of hypertension referred to the proportion among those treated who had an average systolic and diastolic blood pressure of <140/90 mm Hg at the screening camp.
Statistical analysis
The estimations and comparisons of rates were weighted to the standard population in the 6th National General Investigation in Dehui City of Jilin province in 2010, which was the most recent Chinese population census. Complex weighted computation was used to adjust for differing response proportions, selection probabilities, and deviations in the sample compared with the standard population, particularly in terms of gender (male or female), age groups (40–49 years, 50–59 years, 60–69 years, 70– years), and place of residence (rural or urban area). Quantitative variables were presented as means ± SD and compared using Student's t test (normal distribution parameters) or Mann–Whitney–Wilcoxon test (non-normal distribution parameters). Categorical variables were presented as proportions and compared using the Rao–Scott-χ2 test. Finally, the associated influence factors for the prevalence, awareness, treatment, and control of hypertension were analyzed through multivariate binary logistic regression using the surveyed raw data. All statistical analyses were performed using IBM SPSS 17.0 (SPSS Inc., New York, NY, USA). Statistical significance was set at p < 0.05.
Results
General characteristics between participants with and those without hypertension
A total of 4052 participants were included for analysis, including 2335 hypertensive patients (mean age, 56.72 ± 9.23 years) and 1717 normotensive participants (mean age, 52.30 ± 8.77 years). Of the 4052 study subjects, nearly half were from the urban region (51.0%), and 40.0% were men.
Demographic and clinical characteristics of the analyzed subjects according to the hypertension status are provided in Table 1. Compared with participants without hypertension, the hypertension group was usually older and had a higher proportion of males. Dyslipidemia, diabetes, overweight/obesity, physical inactivity, personal and family history of stroke and coronary heart disease, and family history of hypertension were more frequent (p < 0.001, except p = 0.011 for family history of coronary heart disease) in the hypertension group. In addition, the hypertension group had higher TC, TG, LDL-C, and lower HDL-C (p < 0.001, except p = 0.001 for LDL-C) than the normotension group; they also had higher FBG level, and higher neck, waist, and hip circumferences than those of the non-hypertension group (all p < 0.001).
Prevalence, Awareness, treatment, and control of hypertension and their associated factors
As shown in Table 2, the overall adjusted prevalence of hypertension was 57.3%. Among the hypertensive participants, 47.4% were aware of their conditions. Of the affected individuals who were aware of their condition, 78.8% had received hypotensive drugs, but only 10.2% of those who had taken antihypertensive agents now had normal blood pressure. The prevalence, awareness, treatment, and control of hypertension in northeast China by demographic characteristics, such as age, gender, and region, were presented in detail in Table 2.
In a multivariate binary logistic regression analysis, prevalence, awareness, treatment, and control of hypertension were used as dependent variables, the parameters (Table 2) that were significantly associated with prevalence, awareness, treatment, and control of hypertension in univariate analysis (p < 0.1, except for age, gender, and region) were used as independent variables respectively.
After adjusting for potential confounders, multiple logistic regression analysis (Table 3) suggests that the prevalence of hypertension was significantly associated with increasing age, and there was a significant association between gender and the prevalence of hypertension, with men (OR = 1.391; 95% CI: 1.169, 1.656) more likely to have hypertension. In addition, subjects with dyslipidemia (OR = 1.704; 95% CI: 1.476, 1.968), or diabetes (OR = 1.755; 95% CI: 1.376, 2.253) had a higher risk for hypertension. And participants with a personal history of stroke or coronary heart disease, or a family history of hypertension were more likely to have hypertension compared to those without a history of these conditions. However, subjects with education level of junior (OR = 0.819; 95% CI: 0.680, 0.985) or senior (OR = 0.628; 95% CI: 0.481, 0.820) middle school were less likely to have hypertension than those with education level of primary school and below.
As shown in Table 4, increasing age was significantly associated with the awareness of hypertension, and men were less likely to be aware of their conditions. Participants who were overweight/obesity or those with dyslipidemia or diabetes tended to be more aware of their conditions than those otherwise. In addition, subjects with a personal history of coronary heart disease (OR = 2.263; 95% CI: 1.619, 3.164) or stroke (OR = 1.212; 95% CI: 1.003, 1.465), or family history of hypertension (OR = 2.445; 95% CI: 2.026, 2.951), were more inclined to be aware of their conditions compared with those who had no personal or family history.
Table 5 indicates that respondents aged 70– (OR = 1.857; 95% CI: 1.054, 3.270) were more inclined to receive treatment for hypertension than group 40–49 years. As shown by the findings of hypertension awareness, male subjects were unlikely to take hypotensive drugs for their hypertension conditions than female. Participants living in urban areas (OR = 1.758; 95% CI: 1.317, 2.348) were more likely to report drug treatment than those living in rural areas. Subjects with a personal history of stroke (OR = 1.637; 95% CI: 1.044, 2.567) were more inclined to receive treatment than otherwise.
Proportions of different drug classes among hypertension patients using anti-hypertensive drugs overall and by demographic characteristics were shown in Supplementary Table S2. Of all the hypertensives receiving drug therapy, 90.8% (95% CI: 88.2–92.8%) were using monotherapy (one of the western drugs or traditional Chinese medicine), and only 9.2% (95% CI: 7.2–11.8%) were using combination therapy (two or more western drugs or traditional Chinese medicine and western drugs). In addition, the proportion comparisons between total monotherapy and combination therapy showed no significant differences by age group, gender, and residence (all p > 0.05).
Table 6 provides the data showing that subjects aged 70 and above (OR = 0.334; 95% CI: 0.116, 0.957) were less likely to control their hypertension at normal levels than those in age group 40–49 years; and dyslipidemia (OR = 0.600; 95% CI: 0.375, 0.960) was associated with poor control of hypertension. However, subjects using combination of antihypertensive medications compared with that of using monotherapy (OR = 2.924; 95% CI: 1.606, 5.325) or with a family history of coronary heart disease (OR = 1.698; 95% CI: 1.083, 2.664) were more likely to control their hypertension at <140/90 mm Hg.
Discussion
Findings from the population-based cross-sectional survey in northeast China indicated that more than half (57.3%) of adult participants aged 40 years and older were hypertensive. Of these individuals, 47.4% hypertensive subjects were aware of their condition. Although nearly 80% of individuals who were aware of their hypertensive status were receiving antihypertensive medication, blood pressure control was achieved in only 1 in 10 of these individuals.
After entering the 21st century, the first nation-wide study, 2002 China National Nutrition and Health Survey (NNHS) indicated that the overall adjusted prevalence of hypertension in Chinese adults who were 18 years of age and above in 2002 was 18%, with 12% vs. 6%, 28% vs. 29%, and 50% vs. 52% in the age groups of 18–44 years, 45–59 years, and 60 and above years, respectively, in men and women 12]. Our present findings for the overall adjusted prevalence of hypertension was 57.3%, with 47.1, 58.6, 68.5, 74.1% in the age groups of 40–49, 50–59, 60–69, and 70 and above years, respectively. These prevalence rates were much higher than the 2002 NNHS data; however, there was an agreement between the NNHS study and the present findings that the overall prevalence rate was significantly greater for men than for women. These prevalence rates in each age group over 40 years were also significantly higher than the baseline survey of China Kadoorie Biobank Study conducted from June 2004 to August 2009 [13], reporting the adjusted prevalence of hypertension in Chinese adults in the age groups of 40–49, 50–59, 60–69, and 70–74 years old at entry were 22.1, 36.1, 50.7, and 58.4%, respectively. The hypertension prevalence rates reported in our cross-sectional survey in each age group over 40 years were also prominently higher than that reported by the China National Survey of Chronic Kidney Disease, done from 2007 to 2010 [14]; this demonstrated that the adjusted prevalence of hypertension in the age groups of 18–44, 45–59, and 60 and above years were 17.5, 40.1, and 58.2%, respectively. Data collected in 2011-2012 from the China Health and Retirement Longitudinal Study (CHARLS) national study showed that the adjusted prevalence of hypertension in Chinese adults aged 45 years or older in the groups of 50 and below, 50–59, 60–69, 70–79, and 80 and above years were 21.8, 33.8, 26.7, 13.5, and 4.2%, respectively 15]. Another most recent nationally representative survey including 174,621 adults aged 18 years and above from 31 provinces in China between 2013 and 2014, as part of the China Chronic Disease and Risk Factors Surveillance (CCDRFS) survey 16], reported the adjusted prevalence of hypertension in Chinese adults in the groups of 40–49, 50–59, 60–69, and over 70 years were 19.9, 33.8, 48.0, and 61.1%, respectively. Although disparity in sampling design and eligible ages may lead to the variation when estimating prevalence level, the aforementioned epidemiological surveys taken together indicated that the prevalence of hypertension in northeast China was higher than the China national average in the corresponding age group. The prevalence of hypertension in our study was also relatively higher than some regional surveys reported in northern, southern, and central China in recent years, such as Inner Mongolia [17] (28.64, 21.16, and 15.29% in the age groups of 40–49, 50–59, and 60–80 years old, respectively), Zhejiang [18] (17.2, 34.3, and 57.7% in the age groups of 40–49, 50–59, and 60 and above years, respectively), and Henan [19] (22.4, 40.5, 56.4, and 66.3% in the age groups of 35–44, 45–54, 55–64 and 65–74 years old, respectively). However, it is lower than that in Xinjiang, which is located in northwest China [20] (41.0, 61.0, 77.6, and 88.6% in the age groups of 40–49, 50–59, 60–69, and 70 and above years, respectively). Relatively slower economic development and urbanization could be one of the major causes for such a high prevalence of hypertension in northeast China, and a previous study indicated that low socioeconomic status was associated with higher prevalence of hypertension 21]. Another explanation for the particularly high prevalence could be that residents living in the cold northeastern regions consume significantly more sodium than do southerners, which could affect blood pressure 22]. Furthermore, this difference is possibly due to the different lifestyles and dietary habits in northeast China 11]. The cold weather in northeast China limits people’s outdoor physical activity during the long winter, consequently increasing the risk of overweight or obesity and related metabolic abnormalities, such as dyslipidemia and diabetes. These conditions also contributed to the high prevalence of hypertension.
It was also found that the influencing factors for hypertension in our study were increasing age, gender, living in urban areas, overweight/obesity, physical inactivity, and family history of hypertension. This was partly consistent with many other previous studies [12, 14,15,16]. Our study also showed that highly educated people usually had a lower rate of hypertension than those with low education levels. This finding was consistent with several other studies [23,24,25]. It may reflect that factors associated with hypertension are similar among different ethnicities. In addition, individuals with dyslipidemia or diabetes, and subjects with a personal history of stroke or coronary heart disease, were more likely to have hypertension. This reminds health practitioners that people with underlying chronic disease such as dyslipidemia and diabetes, or a history of cardiovascular disease, are at higher risk for hypertension and should thus be given close attention and careful monitoring. Therefore, studies to improve early detection and intervention of hypertension will become increasingly important. In a population-based cross-sectional study, Wang et al. [26] reported that galactosylation of immunoglobulin G is moderately associated with prehypertension and hypertension, and certain types of IgG N-glycan traits (sialylation, core fucosylation, and bisecting N-GlcNAc) are associated with hypertension. They may act as reliable biomarkers to detect people predisposed to hypertension in the early stage.
To reduce the cardiovascular disease burden in China, the prevention and treatment of hypertension with a goal of reducing prevalence and substantially increasing awareness, treatment, and control levels should be a public health priority. Overall, of those individuals with hypertension in our study, 47.4% were aware of their condition; of those who were aware of their condition, 78.8% were being treated. Awareness and treatment rates of hypertension were higher among women compared with men, regardless of age group or residential area. The awareness rate was nearly doubled compared with NNHS study, in which the overall awareness of hypertension was significantly greater for women than for men 12]; however, the treatment rate was similar to that observed in our study. The awareness and treatment rates of hypertension in our present study were also higher than in many previous surveys such as the China Kadoorie Biobank Study [13] (30.5% awareness rate, 46.4% treatment rate) and the CHARLS survey conducted between June 2011 and March 2012 [15] (37.3% awareness rate, 21.1% treatment rate). The awareness rate in our survey was also relatively higher than the CCDRFS survey conducted from 2013 to 2014 16]; however, the treatment rate was lower than that observed in this study (31.9% awareness rate, 82.9% treatment rate). By contrast, among those treated in our survey, only 10.2% had their hypertension controlled. This rate was even lower than the national survey in 2002 12]. As shown in our survey, the awareness and treatment rates of hypertension increased with age. The aforementioned epidemiological surveys indicated that the awareness and treatment rates of hypertension have improved after combined efforts of public health practitioners and professionals in the last decade. In this aspect, Shao et al. [27] did a first attempt to map the medical care ecology of Beijing urban population, which would be useful for highlighting health care system reform, the formulation of better health care policy and improving medical education to meet the expanding demands of the people. Beyond that, Wang et al. [28] had developed a questionnaire-suboptimal health status questionnaire-25 (SHSQ-25), which could be used as an effective instrument for predictive, preventive and personalized medicine, and would enable clinicians and public health workers to predict an individual’s predisposition, such as prehypertension in order to provide targeted preventive measures before the actual onset of the disease. However, the awareness and control rates in northeast China were still under the global average 29], and markedly below those of high-income countries 6], such as the US [74.4% (95% CI: 68.6%-79.4%) awareness and 46.5% (95% CI: 41.1%-51.9%) control rate in 2009 to 2010] [30] and Canada [82.5% (95% CI: 78.5%-86.0%) awareness and 79.0% (95% CI: 71.3%-86.7%) treatment in 2009] 31].
Our present findings also showed that subjects who were overweight/obesity or those with dyslipidemia or diabetes tended to be more aware of their hypertension than those without these conditions. Moreover, subjects with a personal history of stroke were more inclined to be aware of and receive treatment for hypertension; and, participants with a personal history of coronary heart disease were also more likely to be aware of and control their hypertension ( < 140/90 mm Hg). Several studies have suggested that those who have a history of a cardiovascular event often pay close attention to their health, and are particularly concerned about cardiovascular disease risk factors, including hypertension. Moreover, these patients are more probably to comply with treatment with antihypertensive drugs for their hypertension [32, 33]. As our study showed, of all the hypertensives receiving drug therapy, 90.8% (95% CI: 88.2–92.8%) were using monotherapy, and only 9.2% (95% CI: 7.2–11.8%) were using combination therapy, and subjects using combination of antihypertensive medications compared with that of using monotherapy (OR = 2.924; 95% CI: 1.606, 5.325) were more likely to control their hypertension at less than 140/90 mm Hg. This result was in accordance with the PURE China investigation, reporting that few hypertensive individuals received more than one class of drugs, even when their blood pressure was not controlled with a single drug 34]. This current situation in southeast China may explain why control rates were unacceptably low in the hypertensive participants in our study.
Our study had some limitations. First, we used the surveillance definition of hypertension. Blood pressure was measured in a single visit (although two measurements were taken at that visit); and it is known that the overall prevalence of white-coat hypertension in the general population is 10–15% 35]. Thus, its value, as well as the prevalence of hypertension based partly on the measured blood pressure, may have been overestimated. However, there was a systematic review and meta-analysis of prospective studies concluding that white-coat hypertension was also associated with long-term risks of cardiovascular diseases and total mortality compared with normotension 35]. Second, the factor of hypertension-related dietary habits such as salt intake was based on dietary recall instead of a 24-h urinary sodium excretion test. Finally, because our study was a cross-sectional survey, we could not establish cause-and-effect relationships between the observed associations.
Conclusions
In conclusion, our results showed a high prevalence of hypertension among adults aged 40 years and above in northeast China. Although awareness and treatment of hypertension improved over the last decade, the control rate of hypertension remained disproportionately and unacceptably low among hypertensive individuals. Faced with this epidemiological transition, we need innovative strategies that consider the influencing factors to prevent and control hypertension, including promoting healthier diets and lifestyles, reducing inappropriate use of antihypertensive drugs, and strengthening the primary care system.
What is known about topic? |
● Hypertension has been recognized as a major preventable risk factor for cardiovascular disease. |
● Limited studies on the influencing factors associated with the awareness, treatment, and control of hypertension have been undertaken so far in northeast China. |
● Knowledge about this information is crucial for informing hypertension prevention and control strategies. |
What this study adds? |
● This study showed a high prevalence of hypertension in northeast China. |
● Although awareness and treatment rates improved over the last decade, the control rate remained disproportionately and unacceptably low. |
● We need innovative strategies that consider the influencing factors to prevent and control hypertension, including promoting healthier diets and lifestyles, reducing inappropriate use of antihypertensive drugs, and strengthening the primary care system. |
References
Lackland DT, Weber MA. Global burden of cardiovascular disease and stroke: hypertension at the core. Can J Cardiol. 2015;31:569–71.
Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet (London, England). 2008;371:1513–8.
GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1659–724.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.
Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2013;381:1987–2015.
Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441–50.
Bundy JD, He J, Hypertension and related cardiovascular disease burden in China. Annals of global health. 2016;82:227–33
Li Z, Guo X, Zheng L, Yang H, Sun Y. Grim status of hypertension in rural China: results from Northeast China Rural Cardiovascular Health Study 2013. J Am Soc Hypertens. 2015;9:358–64.
Wei Q, Sun J, Huang J, Zhou HY, Ding YM, Tao YC, et al. Prevalence of hypertension and associated risk factors in Dehui City of Jilin Province in China. J Hum Hypertens. 2015;29:64–8.
Sun H, Zou X, Liu L. Epidemiological factors of stroke: a survey of the current status in china. J Stroke. 2013;15:109–14.
Zhang FL, Xing YQ, Wu YH, Liu HY, Luo Y, Sun MS, et al. The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey. Lipids Health Dis. 2017;16:61.
Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008;118:2679–86.
Lewington S, Lacey B, Clarke R, Guo Y, Kong XL, Yang L, et al. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Internal Med. 2016;176:524–32.
Wang J, Zhang L, Wang F, Liu L, Wang H. Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens. 2014;27:1355–61.
Yin M, Augustin B, Fu Z, Yan M, Fu A, Yin P. Geographic distributions in hypertension diagnosis, measurement, prevalence, awareness, treatment and control rates among middle-aged and older adults in China. Sci Rep. 2016;6:37020.
Li Y, Yang L, Wang L, Zhang M, Huang Z, Deng Q, et al. Burden of hypertension in China: a nationally representative survey of 174,621 adults. Int J Cardiol. 2017;227:516–23.
Li G, Wang H, Wang K, Wang W, Dong F, Qian Y, et al. Prevalence, awareness, treatment, control and risk factors related to hypertension among urban adults in Inner Mongolia 2014: differences between Mongolian and Han populations. BMC Public Health. 2016;16:294.
Yang L, Yan J, Tang X, Xu X, Yu W, Wu H. Prevalence, awareness, treatment, control and risk factors associated with hypertension among adults in southern China, 2013. PloS ONE. 2016;11:e0146181.
Fan L, Feng SX, Han B, Wang CC, Gao L, Feng HF, et al. Prevalence, awareness, treatment and control of hypertension in Henan Province, China. Aust J Rural Health. 2014;22:264–9.
Hu Y, Wang Z, Wang Y, Wang L, Han W, Tang Y, et al. Prevalence, awareness, treatment, and control of hypertension among Kazakhs with high salt intake in Xinjiang, China: A Community-based Cross-sectional Study. Sci Rep. 2017;7:45547.
Leng B, Jin Y, Li G, Chen L, Jin N. Socioeconomic status and hypertension: a meta-analysis. J Hypertens. 2015;33:221–9.
Shao S, Hua Y, Yang Y, Liu X, Fan J, Zhang A, et al. Salt reduction in China: a state-of-the-art review. Risk Manag Healthcare Policy. 2017;10:17–28.
Ke L, Ho J, Feng J, Mpofu E, Dibley MJ, Li Y, et al. Prevalence, awareness, treatment and control of hypertension in Macau: results from a cross-sectional epidemiological study in Macau, China. Am J Hypertens. 2015;28:159–65.
Wang H, Zhang X, Zhang J, He Q, Hu R, Wang L, et al. Factors associated with prevalence, awareness, treatment and control of hypertension among adults in Southern China: a community-based, cross-sectional survey. PloS ONE. 2013;8:e62469.
Rubinstein AL, Irazola VE, Calandrelli M, Chen CS, Gutierrez L, Lanas F, et al. Prevalence, awareness, treatment, and control of hypertension in the southern cone of Latin America. Am J Hypertens. 2016;29:1343–52.
Wang Y, Klaric L, Yu X, Thaqi K, Dong J, Novokmet M, et al. The association between glycosylation of immunoglobulin g and hypertension: A Multiple Ethnic Cross-Sectional Study. Medicine. 2016;95:e3379.
Shao S, Zhao F, Wang J, Feng L, Lu X, Du J, et al. The ecology of medical care in Beijing. PloS ONE. 2013;8:e82446.
Wang W, Russell A, Yan Y. Traditional Chinese medicine and new concepts of predictive, preventive and personalized medicine in diagnosis and treatment of suboptimal health. EPMA J. 2014;5:4.
Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310:959–68.
Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012;60:599–606.
McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ. 2011;183:1007–13.
Nolte CH, Jungehulsing GJ, Rossnagel K, Roll S, Haeusler KG, Reich A, et al. Vascular risk factor awareness before and pharmacological treatment before and after stroke and TIA. Eur J Neurol. 2009;16:678–83.
Muntner P, DeSalvo KB, Wildman RP, Raggi P, He J, Whelton PK. Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke. Am J Epidemiol. 2006;163:913–20.
Li W, Gu H, Teo KK, Bo J, Wang Y, Yang J, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China. J Hypertens. 2016;34:39–46.
Huang Y, Huang W, Mai W, Cai X, An D, Liu Z, et al. White-coat hypertension is a risk factor for cardiovascular diseases and total mortality. J Hypertens. 2017;35:677–88.
Acknowledgements
We gratefully acknowledge all study participants, interviewers from the First Hospital of Jilin University, and the support from the Chinese National Center for Stroke Care Quality Control and Management. This project was supported by the National Natural Science Foundation of China to Yi Yang (Grant No. 81571123), the National Key R&D Program of China (2016YFC1301600) to Yi Yang. This project was also supported by the Young Elite Scientists Sponsorship Program by CAST to Zhen-Ni Guo.
Author contributions
Conception and design Y.-Q.X. and Y.Y. Acquisition of the data F.-L.Z. and H.-Y.L. Analysis F.-L.Z. and Y.-H.W. Drafting the manuscript F.-L.Z. Critical revision Z.-N.G., Y.Y. All authors approved the final version to be published.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Zhang, FL., Guo, ZN., Xing, YQ. et al. Hypertension prevalence, awareness, treatment, and control in northeast China: a population-based cross-sectional survey. J Hum Hypertens 32, 54–65 (2018). https://doi.org/10.1038/s41371-017-0003-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41371-017-0003-4
- Springer Nature Limited
This article is cited by
-
The effects of the interaction between BMI and dyslipidemia on hypertension in adults
Scientific Reports (2022)
-
Prevalence, awareness, treatment, and control of hypertension and their determinants: Results from the first cohort of non-communicable diseases in a Kurdish settlement
Scientific Reports (2019)
-
microRNA-21 and hypertension
Hypertension Research (2018)